Semaglutide as a potential treatment for obesity in Smith-Kingsmore syndrome (SKS) patients: A mosaic mutation case report.
- DOI
- 10.1016/j.orcp.2024.03.009
- Published
- 2024-03-01
- Container
- Obes Res Clin Pract
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.orcp.2024.03.009,
title = {Semaglutide as a potential treatment for obesity in Smith-Kingsmore syndrome (SKS) patients: A mosaic mutation case report.},
author = {Bonnet JB and Durieux AT and Tournayre S and Marty L and Sultan A and Avignon A.},
year = {2024},
journal = {Obes Res Clin Pract},
doi = {10.1016/j.orcp.2024.03.009},
url = {https://doi.org/10.1016/j.orcp.2024.03.009}
}RIS
TY - JOUR TI - Semaglutide as a potential treatment for obesity in Smith-Kingsmore syndrome (SKS) patients: A mosaic mutation case report. AU - Bonnet JB AU - Durieux AT AU - Tournayre S AU - Marty L AU - Sultan A AU - Avignon A. PY - 2024 JO - Obes Res Clin Pract DO - 10.1016/j.orcp.2024.03.009 UR - https://doi.org/10.1016/j.orcp.2024.03.009 ER -
APA
JB, B., AT, D., S, T., L, M., A, S., & A., A. (2024). Semaglutide as a potential treatment for obesity in Smith-Kingsmore syndrome (SKS) patients: A mosaic mutation case report.. Obes Res Clin Pract. https://doi.org/10.1016/j.orcp.2024.03.009
Source records
- europe-pmc · retrieved 2026-11-10T14:01:26.194Z
- hal · retrieved 2026-11-10T14:01:26.237Z